Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Neurokinin receptor antagonists.

V Leroy¹, P Mauser, Z Gao

¹Aventis Pharmaceuticals, Route 202-206, Bridgewater, NJ 08807, USA.

Expert Opinion on Investigational Drugs

|November 4, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

On the validity of Wood's law: From bubbly media to liquid foams.

Ultrasonics·2025

Same author

French national protocol for diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in adults and children.

Annales de dermatologie et de venereologie·2025

Same author

["Connected device for monitoring patients treated by prostatectomy: Implementation and qualitative assessment"].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024

Same author

Relationships between obesity markers and bone parameters in community-dwelling older adults.

Aging clinical and experimental research·2024

Same author

[Connected APA tools and prostate cancer: Literature review and experience feedback].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022

Same author

[Sexual and reproductive health of adolescents living with HIV in pediatric care programs in Abidjan : Structured provision of care and perceptions of health care workers in 2019].

Revue d'epidemiologie et de sante publique·2022

Neurokinin receptor (NKr) antagonists show promise for treating emesis and depression. Further clinical trials are underway to explore their potential in other conditions, marking an exciting phase for human proof-of-concept studies.

Area of Science:

Pharmacology
Neuroscience
Drug Discovery

Background:

Recent advancements in developing selective, orally-active neurokinin receptor (NKr) antagonists.
Growing evidence for the involvement of tachykinin peptides in various biological functions.

Purpose of the Study:

To review the progress and potential applications of NKr antagonists.
To highlight the transition of NKr antagonists from animal models to human clinical trials.

Main Methods:

Review of recent scientific literature and clinical trial data.
Analysis of the efficacy and limitations of NKr antagonists in preclinical and clinical studies.

Main Results:

NKr antagonists have shown efficacy in treating emesis and depression.

Related Experiment Videos

Some NKr antagonists have progressed to clinical trials, with initial results published.

Disappointing results were observed in some therapeutic areas, but human proof-of-concept is emerging.

Conclusions:

The field of NKr antagonists is entering a crucial phase of human proof-of-concept.
Continued research may expand the therapeutic indications for NKr antagonists.
Numerous drug candidates are in clinical trials, suggesting a broadening potential for NKr antagonist applications.